[1] |
Wu CZ, Yuan YH, Liu HH, et al. Epidemiologic relationship between periodontitis and type 2 diabetes mellitus[J]. BMC Oral Health, 2020, 20(1):204.
doi: 10.1186/s12903-020-01180-w
|
[2] |
How KY, Song KP, Chan KG. Porphyromonas gingivalis: An overview of periodontopathic pathogen below the gum line[J]. Front Microbiol, 2016, 7:53.
doi: 10.3389/fmicb.2016.00053
pmid: 26903954
|
[3] |
张睿, 葛少华. 二甲双胍潜在用途研究进展[J]. 口腔医学, 2018, 38(10):938-941.
|
[4] |
Hattori Y, Suzuki K, Hattori S, et al. Metformin inhibits cytokine-induced nuclear factor kappa B activation via AMP-activated protein kinase activation in vascular endothelial cells[J]. Hypertension, 2006, 47(6):1183-1188.
doi: 10.1161/01.HYP.0000221429.94591.72
|
[5] |
Deng J, Zeng LS, Lai XY, et al. Metformin protects against intestinal barrier dysfunction via AMPKα1-dependent inhibition of JNK signalling activation[J]. J Cell Mol Med, 2018, 22(1):546-557.
doi: 10.1111/jcmm.13342
pmid: 29148173
|
[6] |
Cahova M, Palenickova E, Dankova H, et al. Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation[J]. Am J Physiol Gastrointest Liver Physiol, 2015, 309(2):G100-G111.
doi: 10.1152/ajpgi.00329.2014
|
[7] |
Son HJ, Lee J, Lee SY, et al. Metformin attenuates experimental autoimmune arthritis through reciprocal regulation of Th17/Treg balance and osteoclastogenesis[J]. Mediators Inflamm, 2014, 2014:973986.
|
[8] |
Tan YM, Chen JS, Jiang YT, et al. The anti-periodontitis action of metformin via targeting NLRP3 inflammasome[J]. Arch Oral Biol, 2020, 114:104692.
doi: 10.1016/j.archoralbio.2020.104692
|
[9] |
Hu P, Zhu CX. Betulinic acid exerts anti-inflammatory activity in human periodontal ligament cells stimulated with lipopolysaccharide and/or high glucose[J]. Endocr Metab Immune Disord Drug Targets, 2023, 23(1):95-104.
doi: 10.2174/1871530322666220509231119
|
[10] |
胡萍, 黄丹. 桦木酸调节血红素加氧酶-1降低脂多糖和尼古丁联合诱导的炎症反应[J]. 临床口腔医学杂志, 2022, 38(7):395-398.
|
[11] |
He Y, Hara H, Núñez G. Mechanism and regulation of NLRP3 inflammasome activation[J]. Trends Biochem Sci, 2016, 41(12):1012-1021.
doi: S0968-0004(16)30148-7
pmid: 27669650
|
[12] |
Elliott EI, Sutterwala FS. Initiation and perpetuation of NLRP3 inflammasome activation and assembly[J]. Immunol Rev, 2015, 265(1):35-52.
doi: 10.1111/imr.12286
pmid: 25879282
|
[13] |
Cassel SL, Joly S, Sutterwala FS. The NLRP3 inflammasome:A sensor of immune danger signals[J]. Semin Immunol, 2009, 21(4):194-198.
doi: 10.1016/j.smim.2009.05.002
|
[14] |
García-Hernández AL, Muñoz-Saavedra ÁE, González-Alva P, et al. Upregulation of proteins of the NLRP3 inflammasome in patients with periodontitis and uncontrolled type 2 diabetes[J]. Oral Dis, 2019, 25(2):596-608.
doi: 10.1111/odi.13003
pmid: 30422379
|
[15] |
Wu M, Lu L, Guo KF, et al. Vitamin D protects against high glucose-induced pancreatic β-cell dysfunction via AMPK-NLRP3 inflammasome pathway[J]. Mol Cell Endocrinol, 2022, 547:111596.
doi: 10.1016/j.mce.2022.111596
|
[16] |
Vo TTT, Lee CW, Chiang YC, et al. Protective mechanisms of Taiwanese green propolis toward high glucose-induced inflammation via NLRP3 inflammasome signaling pathway in human gingival fibroblasts[J]. J Periodontal Res, 2021, 56(4):804-818.
doi: 10.1111/jre.v56.4
|
[17] |
Huang X, Yang X, Ni J, et al. Hyperglucose contributes to periodontitis:Involvement of the NLRP3 pathway by engaging the innate immunity of oral gingival epithelium[J]. J Periodontol, 2015, 86(2):327-335.
doi: 10.1902/jop.2014.140403
pmid: 25325516
|
[18] |
Li AY, Zhang SH, Li J, et al. Metformin and resveratrol inhibit Drp1-mediated mitochondrial fission and prevent ER stress-associated NLRP3 inflammasome activation in the adipose tissue of diabetic mice[J]. Mol Cell Endocrinol, 2016, 434:36-47.
doi: 10.1016/j.mce.2016.06.008
pmid: 27276511
|
[19] |
Lee HM, Kim JJ, Kim HJ, et al. Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes[J]. Diabetes, 2013, 62(1):194-204.
doi: 10.2337/db12-0420
|
[20] |
Araújo AA, Pereira ASBF, Medeiros CACX, et al. Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitis[J]. PLoS One, 2017, 12(8):e0183506.
doi: 10.1371/journal.pone.0183506
|
[21] |
Bak EJ, Park HG, Kim M, et al. The effect of metformin on alveolar bone in ligature-induced periodontitis in rats:A pilot study[J]. J Periodontol, 2010, 81(3):412-419.
doi: 10.1902/jop.2009.090414
|
[22] |
Zhou XY, Zhang P, Wang Q, et al. Metformin ameliorates experimental diabetic periodontitis independently of mammalian target of rapamycin (mTOR) inhibition by reducing NIMA-related kinase 7 (Nek7) expression[J]. J Periodontol, 2019, 90(9):1032-1042.
doi: 10.1002/JPER.18-0528
pmid: 30945296
|
[23] |
Zhou XY, Wang Q, Nie L, et al. Metformin ameliorates the NLPP3 inflammasome mediated pyroptosis by inhibiting the expression of NEK7 in diabetic periodontitis[J]. Arch Oral Biol, 2020, 116:104763.
doi: 10.1016/j.archoralbio.2020.104763
|
[24] |
Chen MY, Ye XJ, He XH, et al. The signaling pathways regulating NLRP3 inflammasome activation[J]. Inflammation, 2021, 44(4):1229-1245.
doi: 10.1007/s10753-021-01439-6
|
[25] |
Yang F, Qin Y, Wang YQ, et al. Metformin inhibits the NLRP3 inflammasome via AMPK/mTOR-dependent effects in diabetic cardiomyopathy[J]. Int J Biol Sci, 2019, 15(5):1010-1019.
doi: 10.7150/ijbs.29680
pmid: 31182921
|
[26] |
Billingham LK, Stoolman JS, Vasan K, et al. Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation[J]. Nat Immunol, 2022, 23(5):692-704.
doi: 10.1038/s41590-022-01185-3
pmid: 35484407
|